School of Medicine
Showing 11-20 of 40 Results
-
Sarah S. Donaldson, MD
Catharine and Howard Avery Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsCombined Modality Treatment of Cancer
Late Effects of Treatment
Genetic Effects of Cancer
Rhabdomyosarcoma
Hodgkins Disease
Pediatric Radiation Oncolgy
Pediatric Oncolgy
Breast Cancer
Conformal Radiotherapy/IMRT
Radiotherapy for Benign Diseases -
Michael Gensheimer
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
Current Research and Scholarly InterestsIn addition to my clinical research in head and neck and lung cancer, I work on the application of computer science and machine learning to cancer research. I develop tools for analyzing large datasets to improve outcomes and safety of cancer treatment. I developed a machine learning prognostic model using data from around 13,000 patients with metastatic cancer which performs better than traditional models and physicians [PubMed ID 33313792]. We recently completed a prospective randomized study in thousands of patients in which the model was used to help improve advance care planning conversations.
I also work on the methods underpinning observational and predictive modeling research. My open source nnet-survival software that allows use of neural networks for survival modeling has been used by researchers internationally. In collaboration with the Stanford Research Informatics Center, I examined how electronic medical record (EMR) survival outcome data compares to gold-standard data from a cancer registry [PubMed ID 35802836]. The EMR data captured less than 50% of deaths, a finding that affects many studies being published that use EMR outcomes data. -
Alireza Ghiam, MD, MS
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
BioDr. Ghiam is an American and Canadian Board-Certified Radiation Oncologist with the Stanford Medicine Cancer Center and a Clinical Associate Professor in the Department of Radiation Oncology at Stanford University School of Medicine. After completing an MSc in Molecular Biology & Genetics at the University of Montreal, he completed a residency in Radiation Oncology and fellowship in Head & Neck and GU radiation oncology at the University of Toronto.
He diagnoses and treats various conditions specializing in head & neck cancer, genitourinary malignancies, and metastatic disease. His treatment expertise includes oligometastatic disease, palliative radiation therapy, stereotactic ablative radiotherapy, and proton therapy.
Dr. Ghiam has contributed to the field through his authorship of technology- and biology-based publications and collaboration in clinical trials. He has been recognized by awards from the American Society for Radiation Oncology (ASTRO), the Canadian Association of Radiation Oncology (CARO), and the Universities of Toronto and Pennsylvania. In recognition of his educational work, he received two prestigious teaching awards for teaching residents and medical students. He has presented his research work nationally and internationally and authored and co-authored several papers.
Dr. Ghiam's interest lies in exploring novel AI-powered technologies that can enhance patient outcomes, and bridge health equity gaps in radiation oncology. He is also interested in clinical trials of innovative radiation therapy techniques with a focus on leveraging technology and biology to reduce toxicity and increase precision.
Dr. Ghiam is dedicated to academia, education, and diversity. He is committed to improving patient outcomes and changing the role of supportive care in radiation oncology by promoting quality standards and utilizing palliative radiotherapy to enhance the quality of life for his patients.
Dr. Ghiam practices evidence-based care with compassion and treats his patients as he would his own family. -
Iris C. Gibbs, MD, FACR, FASTRO
Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery
On Leave from 05/01/2024 To 04/22/2025Current Research and Scholarly InterestsDr. Gibbs is a board-certified radiation oncologist who specializes in the treatment of CNS tumors. Her research focuses on developing new radiation techniques to manage brain and spinal tumors in adults and children. Dr. Gibbs has gained worldwide acclaim for her expertise in Cyberknife robotic radiosurgery.
-
Richard Hoppe
Henry S. Kaplan-Harry Lebeson Professor of Cancer Biology
Current Research and Scholarly InterestsIrradiation immunosuppression; total body irradiation;, psychosocial effects of cancer treatment; treatment of lymphoma;, mycosis fungoides.
-
Anusha Kalbasi, MD
Associate Professor of Radiation Oncology (Radiation Therapy)
BioDr. Kalbasi is radiation oncologist and physician-scientist at the Stanford Cancer Institute, specializing in the treatment of patients with solid malignancies, especially sarcoma and melanoma. He actively leads early phase clinical trials related to immunotherapy and/or radiation therapy.
Dr. Kalbasi's laboratory studies cancer immunology, with a focus on manipulating the cell-intrinsic signals of immune cells and cancer cells to influence the outcomes of immunotherapy and/or radiation. The lab integrates a variety of approaches including cell and protein engineering, synthetic biology, cell signaling, genomics, and analysis of samples from patients on clinical trials. The lab is actively engaged in projects involving engineering T cell therapies (TCR, CAR, TIL), T cell engagers, cytokine therapies, innate immune agonists and radiation therapy.
Dr. Kalbasi was previously assistant professor of radiation oncology at the David Geffen School of Medicine at UCLA and chief of sarcoma radiotherapy at the UCLA Jonsson Comprehensive Cancer Center, where he was named a NextGen Star by the American Association of Cancer Research. Dr. Kalbasi’s work has been published in leading journals including Nature, Science Translational Medicine, JAMA Oncology, Lancet Oncology, Nature Cancer and Cancer Discovery. -
Daniel Kapp
Professor of Radiation Oncology, Emeritus
Current Research and Scholarly InterestsGynecologic malignancies; Rectal/and cancer; Breast Cancer; Hodgkin's disease; Hyperthermia; intraoperative radiation therapy; High dose rate radiation therapy; Predictive assays; Patterns of tumor spread; Health care finance.
